BACKGROUND: It is well accepted that exercise can decrease breast cancer risk. Limited clinical evidence suggests that this risk could be mediated through changes in estrogen metabolism in premenopausal women. Our objective was to investigate the effects of exercise on premenopausal estrogen metabolism pertinent to breast cancer risk. METHODS:Sedentary, healthy, young eumenorrheic women were randomized into an intervention of 30 minutes of moderate-to-vigorous aerobic exercise five times a week for approximately 16 weeks (n = 212), or into a usual-lifestyle sedentary control group (n = 179). Urinary levels of estrogens [estrone [E1], estradiol, and estriol] and nine estrogen metabolites were measured at baseline and at study end by liquid chromatography/tandem mass spectrometry. The ratios of 2-hydroxyestrone to 16α-hydroxyestrone (2-OHE1/16α-OHE1) and 2-OHE1 to 4-hydroxyestrone (2- OHE1/4-OHE1) were also calculated. RESULTS: The exercise intervention resulted in significant increases in aerobic fitness and lean body mass and a significant decrease in percent body fat. For exercisers who completed the study (n = 165), 2-OHE1/16α-OHE1 increased significantly (P = 0.043), whereas E1 decreased significantly (P = 0.030) in control participants (n = 153). The change from baseline in 2-OHE1/16α-OHE1 was significantly different between groups (P = 0.045), even after adjustment for baseline values. CONCLUSIONS: The exercise intervention resulted in a significant increase in the 2-OHE1/16α-OHE1 ratio but no differences in other estrogen metabolites or ratios. IMPACT: Our results suggest that changes in premenopausal estrogen metabolism may be a mechanism by which increased physical activity lowers breast cancer risk.
RCT Entities:
BACKGROUND: It is well accepted that exercise can decrease breast cancer risk. Limited clinical evidence suggests that this risk could be mediated through changes in estrogen metabolism in premenopausal women. Our objective was to investigate the effects of exercise on premenopausal estrogen metabolism pertinent to breast cancer risk. METHODS: Sedentary, healthy, young eumenorrheic women were randomized into an intervention of 30 minutes of moderate-to-vigorous aerobic exercise five times a week for approximately 16 weeks (n = 212), or into a usual-lifestyle sedentary control group (n = 179). Urinary levels of estrogens [estrone [E1], estradiol, and estriol] and nine estrogen metabolites were measured at baseline and at study end by liquid chromatography/tandem mass spectrometry. The ratios of 2-hydroxyestrone to 16α-hydroxyestrone (2-OHE1/16α-OHE1) and 2-OHE1 to 4-hydroxyestrone (2- OHE1/4-OHE1) were also calculated. RESULTS: The exercise intervention resulted in significant increases in aerobic fitness and lean body mass and a significant decrease in percent body fat. For exercisers who completed the study (n = 165), 2-OHE1/16α-OHE1 increased significantly (P = 0.043), whereas E1 decreased significantly (P = 0.030) in control participants (n = 153). The change from baseline in 2-OHE1/16α-OHE1 was significantly different between groups (P = 0.045), even after adjustment for baseline values. CONCLUSIONS: The exercise intervention resulted in a significant increase in the 2-OHE1/16α-OHE1 ratio but no differences in other estrogen metabolites or ratios. IMPACT: Our results suggest that changes in premenopausal estrogen metabolism may be a mechanism by which increased physical activity lowers breast cancer risk.
Authors: A M Kriska; W C Knowler; R E LaPorte; A L Drash; R R Wing; S N Blair; P H Bennett; L H Kuller Journal: Diabetes Care Date: 1990-04 Impact factor: 19.112
Authors: Jay H Fowke; Dai Qi; H Leon Bradlow; Xiao Ou Shu; Yu Tang Gao; Jin Rong Cheng; Fan Jin; Wei Zheng Journal: Steroids Date: 2003-01 Impact factor: 2.668
Authors: H Adlercreutz; T Fotsis; K Höckerstedt; E Hämäläinen; C Bannwart; S Bloigu; A Valtonen; A Ollus Journal: J Steroid Biochem Date: 1989 Impact factor: 4.292
Authors: Kathryn H Schmitz; Nancy I Williams; Despina Kontos; Susan Domchek; Knashawn H Morales; Wei-Ting Hwang; Lorita L Grant; Laura DiGiovanni; Domenick Salvatore; Desire' Fenderson; Mitchell Schnall; Mary Lou Galantino; Jill Stopfer; Mindy S Kurzer; Shandong Wu; Jessica Adelman; Justin C Brown; Jerene Good Journal: Breast Cancer Res Treat Date: 2015-10-28 Impact factor: 4.872
Authors: Jeremy S Haley; Elizabeth A Hibler; Shouhao Zhou; Kathryn H Schmitz; Kathleen M Sturgeon Journal: Cancer Date: 2019-09-30 Impact factor: 6.860
Authors: Cher M Dallal; Louise A Brinton; Charles E Matthews; Ruth M Pfeiffer; Terryl J Hartman; Jolanta Lissowska; Roni T Falk; Montserrat Garcia-Closas; Xia Xu; Timothy D Veenstra; Gretchen L Gierach Journal: Med Sci Sports Exerc Date: 2016-03 Impact factor: 5.411
Authors: Talia N Crawford; Andrea Y Arikawa; Mindy S Kurzer; Kathryn H Schmitz; William R Phipps Journal: Fertil Steril Date: 2015-09-16 Impact factor: 7.329
Authors: Hazel B Nichols; Minouk J Schoemaker; Lauren B Wright; Craig McGowan; Mark N Brook; Kathleen M McClain; Michael E Jones; Hans-Olov Adami; Claudia Agnoli; Laura Baglietto; Leslie Bernstein; Kimberly A Bertrand; William J Blot; Marie-Christine Boutron-Ruault; Lesley Butler; Yu Chen; Michele M Doody; Laure Dossus; A Heather Eliassen; Graham G Giles; Inger T Gram; Susan E Hankinson; Judy Hoffman-Bolton; Rudolf Kaaks; Timothy J Key; Victoria A Kirsh; Cari M Kitahara; Woon-Puay Koh; Susanna C Larsson; Eiliv Lund; Huiyan Ma; Melissa A Merritt; Roger L Milne; Carmen Navarro; Kim Overvad; Kotaro Ozasa; Julie R Palmer; Petra H Peeters; Elio Riboli; Thomas E Rohan; Atsuko Sadakane; Malin Sund; Rulla M Tamimi; Antonia Trichopoulou; Lars Vatten; Kala Visvanathan; Elisabete Weiderpass; Walter C Willett; Alicja Wolk; Anne Zeleniuch-Jacquotte; Wei Zheng; Dale P Sandler; Anthony J Swerdlow Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-06-09 Impact factor: 4.254
Authors: Jing Peng; Sibele I Meireles; Xia Xu; William E Smith; Michael J Slifker; Stacy L Riel; Shumenghui Zhai; Guo Zhang; Xiang Ma; Mindy S Kurzer; Grace X Ma; Margie L Clapper Journal: Oncotarget Date: 2017-11-01